Tags : IQ Capital

B2B

Nyobolt secures £7.5 million Series A investment led by IQ

$10m Series A fundraise for state-of-the-art battery company Nyobolt  Years of research leads to the commercialisation of pioneering battery technology which delivers high power and ultra-fast charging Cambridge, 25th February: Nyobolt, a cutting-edge battery company, defining a new category of ultra-high power technology, has secured $10 million in Series A funding, led by IQ Capital […]Read More

IoT

Cambridge GaN Devices secures £6.8 million Series A investment co-led

Cambridge GaN Devices raises $9.5m Series A to accelerate the deployment of energy efficient devices reshaping the future of power electronics Cambridge University spinout’s latest funding round will be used to double staff and expand its GaN product portfolio following decades of research in power devices Cambridge, 18th February 2021 – Cambridge GaN Devices (CGD) has raised […]Read More

B2B

CybSafe secures £5.6 million Series A investment led by IQ

CybSafe secures £5.6 million Series A investment round CybSafe, London, 28 January 2021 – CybSafe, the behavioural security platform that’s transforming the way organisations manage human cyber risk, today announced a £5.6m ($7.9m) Series A round. It was led by deep tech investors, IQ Capital with participation from Hannover Digital Investments GmbH (HDI Group) and B8 Ventures. The investment […]Read More

Seed

Pangaea Data secures Seed Follow On investment led by IQ

Pangaea Data raises further funding to accelerate deployment of its breakthrough AI with pharmaceutical companies and hospitals to improve patient outcomes Novel unsupervised AI is used by Biopharmaceutical and Healthcare organisations to diagnose patients earlier and connect them to the right therapies, clinical trials and drug discovery studies at scale and at 50 times speed […]Read More

Yorkshire & The Humber

Opteran Technologies secures £2.1 million Seed investment led by IQ

Opteran Secures £2.1m in Seed Funding to Solve Autonomy Using Natural Intelligence Inspired by Insects Start-up developing lightweight, low cost silicon brains to enable robots and autonomous vehicles to see, sense, navigate and make decisions Sheffield UK, 24 November 2020 – Opteran, the Natural Intelligence company, has raised £2.1 million in seed funding. Opteran will […]Read More

East of England

Arjun Technology Ventures (t/a KisanHub) secures £1.12 million Series A

KisanHub raises £1.12m to connect agri-food supply chains from seed to sale The online SaaS platform that streamlines data collection, decision making and communications for supply chains, secures funding for £1.12m. Supply chains are one of the most complicated and least efficient areas when it comes to delivering goods from farmers to consumers.  Cambridge based […]Read More

Seed

Nu Quantum secures £2.1m Seed investment led by Amadeus Capital

Nu Quantum raises £2.1m Seed investment to accelerate the commercialisation of pioneering quantum photonics hardware Investment in Cambridge-based Nu Quantum will go towards a new state-of-the-art lab, a major recruitment drive, and further R&D for quantum photonics technologies Cambridge, Monday 5th October 2020 – Nu Quantum, the quantum photonics company, has raised £2.1 million in […]Read More

Series A

AccelerComm secures £5.8 million Series A investment led by IQ

University of Southampton spinout to use funding to scale IP technology business that significantly reduces latency and increases spectral efficiency Southampton, 21 September 2020: AccelerComm – The Southampton University spinout supercharging 5G, satellite and other wireless communications with IP which increases spectrum efficiency and reduces latency – has raised £5.8m in Series A funding in […]Read More

HealthTech

Neurovalens secures £5 million Series A Follow On investment led

July 20, 2020 Health tech company Neurovalens raises more than £5 million to advance medical device approvals of its neurostimulation technology Northern Ireland founded scale-up business aims to treat conditions including diabetes, insomnia, anxiety and obesity Neurovalens, a global healthtech company headquartered in Belfast and San Diego, has raised £5.1 million in funding, which will be […]Read More